Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Safety and Efficacy of AST-004 in Patients with Mild Complicated Traumatic Brain Injury
The NetherlandsTicagrelor versus placebo to prevent cerebral ischemia in patients with low‑grade aneurysmal subarachnoid hemorrhage
FranceMontelukast Sodium for disease-modifying treatment in patients with mild‑moderate Parkinson’s disease: open‑label phase II extension study
SwedenSafety, CNS penetration and target engagement of Mirivadelgat in participants with Parkinson's disease
NorwayIntravenous ferric carboxymaltose for drug‑resistant restless legs syndrome: a randomized delayed‑start trial in adults
FrancePhase 3 Randomized Double‑Blind Placebo‑Controlled Study of Intravenous sgt-003 in Ambulatory Male Patients with Duchenne Muscular Dystrophy
BelgiumStudy to evaluate the effect of methylphenidate hydrochloride on the time to wake up in patients in a coma due to acute brain injury
AustriaA study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.
FranceA study of RVU120 and everolimus for children with recurrent or progressive medulloblastoma
PolandStudy of the safety and effectiveness of tolDC therapy in patients with progressive forms of multiple sclerosis
BelgiumEffect of cladribine tablets on immune synapse in patients with relapsing multiple sclerosis
GreeceA Phase 3 Study Evaluating the Efficacy and Safety of Subcutaneous Nomlabofusp in Adults and Children with Friedreich’s Ataxia
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
